Next events

16 january 2019  First challenge innovation awards at la pitié salpêtrière hospital

LallianSe provides precision support and actions to healthcare start-ups, scale-ups or SME.

LallianSe has a unique proposition : identifying, building and managing part-time seasoned Experts or Expert teams to drive key responsibilities within life sciences companies.

By building a virtual leadership team, LallianSe

  • helps companies to move from Vision to Strategy to Operational Development
  • fosters their growth in the most time- and cost-effective manner, to deliver maximum value from their innovations

LallianSe is led by seasoned executives in the field of life science venture capital, international development and registration of innovative molecules and medical devices.

Julie Rachline

Helene
Peyro-Saint-Paul

To be announced soon!

Pascale Maisonneuve

Shahrzad Moradi

Julie, Hélène and Pascale combine more than 80 years of experience in regulatory, medical and clinical affairs, product positioning, market access, business development, investing, and corporate governance. Their experiences allow to understand, challenge, and propose adequate solutions with Expert- in-residence team to the life sciences companies ecosystem.

Shahrzad manages the office and the Experts community, providing efficient administrative support and is the little fairy of LallianSe.

Our commitments are:

  • Create and manage tailored Expert-in-residence senior teams that provides strategic and operational support
  • Maximize operational efficacy
  • Invest capital effectively
  • Mesure impact on company performance

LallianSe Experts

LallianSe is built on a community of more than 20 Experts to date, active in 4 strategic domains :

  • Corporate strategy and financing
  • Medical and product strategy, market access
  • Regulatory affairs and quality assurance
  • Business strategy and operations

Our Experts are seasoned executives with the right balance of strategic thinking, operational competencies and international experience, illustrated by significant achievements along their respective careers. They are selected not only on their achievements and skills, but mostly on their philosophy and interpersonal skills.

In addition, LallianSe has established strong ties with a variety of support functions (e.g. biostatistics, communication, HR, finance, IP management, etc.), and has access to a large network of other recognized life sciences experts and KOLs, notably with its offices located at la Pitié Salpêtrière hospital in Paris.

Our Ecosystem

 

 

Selected Ongoing missions

Nanobiotix

Nanobiotix

Expert mission :

  • Investors relations
  • Investor Experience strategy
Undisclosed

Undisclosed

Experts missions :

  • Regulatory strategy
  • Clinical affairs
  • Corporate strategy and financing options

LallianSe manages responsibilities for a vast diversity of clients, from early-stage to listed companies, from France to Japan, from medical devices to drugs or services.

Experts team are created based on mandatory execution capabilities, know-how and evaluated achievements, and are driven and managed efficently by a unique chemistry.

 

.

Selected news

Advicenne receives approval for Marketing Authorization for ADV6209 in Pediatric Moderate Sedation

Advicenne receives approval for Marketing Authorization for ADV6209 in Pediatric Moderate Sedation

Advicenne receives approval for Marketing Authorization for ADV6209 in Pediatric Moderate Sedation

DTAMedical lance son traitement des plaies aiguës sans contact

DTAMedical lance son traitement des plaies aiguës sans contact

Grâce à l’obtention du marquage CE pour son dispositif médical VistaCare One, annoncé ce mercredi, la société jurassienne va pouvoir commercialiser une première version auprès des hôpitaux dès ce deuxième trimestre.
NANOBIOTIX  ANNOUNCES POSITIVE PHASE II/III  TOPLINE DATA IN SOFT TISSUE SARCOMA WITH NBTXR3

NANOBIOTIX ANNOUNCES POSITIVE PHASE II/III TOPLINE DATA IN SOFT TISSUE SARCOMA WITH NBTXR3

Nanobiotix, a late clinical stage nanomedicine company pioneering new approaches in the treatment of cancer, announced today positive topline results of the Phase II/III act.in.sarc trial evaluating NBTXR3 in Soft Tissue Sarcoma.

Selected partners   

LallianSe is a unique ecosystem dedicated to life sciences companies and innovators. We strive to accelerate the development of products and services than can change the lives of patients. Join us in the Adventure!

Hôpital de la Salpêtrière

LallianSe LAB offices :
HEUYER Building, 3rd Floor, Hôpital de la Pitié Salpêtrière,
47-83 boulevard de l'hôpital, 75013 Paris, France

9 + 2 =